quick note from an analyst:
"This is earlier than expected
Most important study we are aware of. Has a placebo.
This is the trial run by the govt – NOT the GILD trial we were expecting results out today or tomorrow.
This was NOT just in severe patients. This is MODERATE and severe
It hit the primary endpoint which means it hit the efficacy end point which for dummies means it works. "
Caffeine 发表于 4/29/2020 8:48:37 AM [url=https://forums.huaren.us/showtopic.aspx?topicid=2541213&postid=83808345#83808345][img][/img][/url]
建议加上今早Dr. Scott Gottlieb 在CNBC的采访，他说话一直非常谨慎。
As we've been saying for some time now, accumulating data on Remdesivir suggests it's active against covid and there's now enough data to support consideration of access under an emergency use authorization by FDA. The data from NIAID study should push this firmly over the line.
Gilead’s remdesivir, along with therapeutic antibodies and improved testing, is part of “a robust toolbox,” Dr. Scott Gottlieb says. “All of this is going to put us in a much different posture for the fall.” [url=https://t.co/xl18L8D9XO?amp=1]https://cnb.cx/2SgbRfu[/url]
https://twitter.com/ScottGottliebMD/status/1255484418745151495?s=20